| Operative characteristics . | n, 88 (%) . |
|---|---|
| Concomitant lymph node procedure | |
| Yes | 73 (82.9%) |
| No | 15 (17.0%) |
| ADM utilization | |
| TE with ADM | 78 (88.6) |
| TE without ADM | 10 (11.4) |
| TE location | |
| Pre-pectoral | 24 (27.3) |
| Sub-pectoral | 64 (72.7) |
| Number of drains per pocket | |
| 1 | 12 (13.6) |
| 2 | 76 (86.4) |
| Surgeon | |
| A | 65 (73.9) |
| B | 11 (12.5) |
| C | 6 (6.8) |
| D | 5 (5.7) |
| E | 1 (1.1) |
| Solution randomized to malignant breast pocketa | |
| CHG | 41 (50.6) |
| Triple antibiotic | 40 (49.4) |
| Length of operation (min)b, mean [25,75 %ile] | 284.1 [224.3, 328.8] |
| Operative characteristics . | n, 88 (%) . |
|---|---|
| Concomitant lymph node procedure | |
| Yes | 73 (82.9%) |
| No | 15 (17.0%) |
| ADM utilization | |
| TE with ADM | 78 (88.6) |
| TE without ADM | 10 (11.4) |
| TE location | |
| Pre-pectoral | 24 (27.3) |
| Sub-pectoral | 64 (72.7) |
| Number of drains per pocket | |
| 1 | 12 (13.6) |
| 2 | 76 (86.4) |
| Surgeon | |
| A | 65 (73.9) |
| B | 11 (12.5) |
| C | 6 (6.8) |
| D | 5 (5.7) |
| E | 1 (1.1) |
| Solution randomized to malignant breast pocketa | |
| CHG | 41 (50.6) |
| Triple antibiotic | 40 (49.4) |
| Length of operation (min)b, mean [25,75 %ile] | 284.1 [224.3, 328.8] |
aFive patients had bilateral breast cancer; 12 patients had no breast cancer. No significant association with malignancy laterality and irrigation solution (P = 0.88). ADM, acellular dermal matrix; CHG, chlorhexidine gluconate; TE, tissue expander.
bTotal length of operation, including mastectomies and lymph node procedure(s).
| Operative characteristics . | n, 88 (%) . |
|---|---|
| Concomitant lymph node procedure | |
| Yes | 73 (82.9%) |
| No | 15 (17.0%) |
| ADM utilization | |
| TE with ADM | 78 (88.6) |
| TE without ADM | 10 (11.4) |
| TE location | |
| Pre-pectoral | 24 (27.3) |
| Sub-pectoral | 64 (72.7) |
| Number of drains per pocket | |
| 1 | 12 (13.6) |
| 2 | 76 (86.4) |
| Surgeon | |
| A | 65 (73.9) |
| B | 11 (12.5) |
| C | 6 (6.8) |
| D | 5 (5.7) |
| E | 1 (1.1) |
| Solution randomized to malignant breast pocketa | |
| CHG | 41 (50.6) |
| Triple antibiotic | 40 (49.4) |
| Length of operation (min)b, mean [25,75 %ile] | 284.1 [224.3, 328.8] |
| Operative characteristics . | n, 88 (%) . |
|---|---|
| Concomitant lymph node procedure | |
| Yes | 73 (82.9%) |
| No | 15 (17.0%) |
| ADM utilization | |
| TE with ADM | 78 (88.6) |
| TE without ADM | 10 (11.4) |
| TE location | |
| Pre-pectoral | 24 (27.3) |
| Sub-pectoral | 64 (72.7) |
| Number of drains per pocket | |
| 1 | 12 (13.6) |
| 2 | 76 (86.4) |
| Surgeon | |
| A | 65 (73.9) |
| B | 11 (12.5) |
| C | 6 (6.8) |
| D | 5 (5.7) |
| E | 1 (1.1) |
| Solution randomized to malignant breast pocketa | |
| CHG | 41 (50.6) |
| Triple antibiotic | 40 (49.4) |
| Length of operation (min)b, mean [25,75 %ile] | 284.1 [224.3, 328.8] |
aFive patients had bilateral breast cancer; 12 patients had no breast cancer. No significant association with malignancy laterality and irrigation solution (P = 0.88). ADM, acellular dermal matrix; CHG, chlorhexidine gluconate; TE, tissue expander.
bTotal length of operation, including mastectomies and lymph node procedure(s).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
